Pantoprazole (Protonix) Powder for Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 21, 2017 Category: Drugs & Pharmacology Source Type: news
Popular heartburn drugs linked to gradual yet'silent' kidney damage
The sudden onset of kidney problems often serves as a warning for doctors to discontinue patients ' use of proton pump inhibitors (PPIs), sold under brand names Prevacid, Prilosec, Nexium and Protonix, among others. But a new study indicates that more than half of patients who develop chronic kidney damage while taking the drugs don ' t experience acute kidney problems beforehand, according to researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 22, 2017 Category: Science Source Type: news
Protonix I.V. (Pantoprazole Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 29, 2016 Category: Drugs & Pharmacology Source Type: news
This Popular Kind Of Heartburn Medicine Can Increase Stroke Risk
This study further questions the cardiovascular safety of these drugs,” Sehested said.
Although the study found an association between PPIs and stroke risk, it does not prove cause and effect. More studies are needed, and doctors should consider if and for how long patients should take these drugs, the researchers said. [7 Bizarre Drug Side Effects]
PPIs are not the only medicines available to treat heartburn. The researchers noted that another type of heartburn medication, called a histamine H2 antagonist, was found to have no association with stroke risk in the study. Histamine H2 antagonists include famotidine (Pe...
Source: Science - The Huffington Post - November 21, 2016 Category: Science Source Type: news
How to interpret urine drug tests for marijuana: a review
Linda Parton/shutterstock.com
4 out of 5 stars
Interpretation of Workplace Tests for Cannabinoids. Kulig K. J Med Toxicol 2016 Sep 29 [Epub ahead of print]
Abstract
The interpretation of workplace urine drug tests for marijuana often becomes a point of contention in workman’s compensation cases or proceedings moving towards firing an employee. In may experience, the court or arbitrator not infrequently gets the science of these tests wrong. Such misinterpretation can be devastating for the employee who is at risk of losing his or her job and benefits. This concise review of the subject by Ken Kulig gets the science r...
Source: The Poison Review - November 19, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical marijuana occupational medicine THC THC acid THC-COOH THCa urine drug screen workman's compensation Source Type: news
Popular heartburn medications linked to higher risk of stroke
Proton pump inhibitors, including Prilosec, Protonix, Prevacid and Nexium, are used to treat heartburn, but may increase the risk of ischemic stroke, new research shows. (Source: CNN.com - Health)
Source: CNN.com - Health - November 15, 2016 Category: Consumer Health News Source Type: news
Could Common Heartburn Drugs Up Stroke Risk?
TUESDAY, Nov. 15, 2016 -- A popular category of heartburn medications -- including Nexium, Prevacid, Prilosec and Protonix -- may increase your risk of stroke, a new study suggests.
Known as proton pump inhibitors (PPIs), these drugs increased... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 15, 2016 Category: Journals (General) Source Type: news
Aurobindo Pharma, Cadila recall drugs from US market
Pantoprazole Sodium delayed-release tablets are used for treatment of erosive inflammation of the esophagus due to acid reflux. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 21, 2016 Category: Pharmaceuticals Source Type: news
Florida to get $9.3M in multi-state settlement with Wyeth
Florida Attorney General Pam Bondi’s office announced a multi-state settlement against Wyeth, a wholly owned subsidiary of Pfizer Inc., resolving allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of Protonix Oral and Protonix IV.
As part of the settlement, Wyeth agrees to pay $784.6 million to multiple state governments and the United States. More than $371 million of this amount will go to the Medicaid Program. As part of the settlement,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 4, 2016 Category: Biotechnology Source Type: news
$45 million! North Carolina's share from Medicaid settlement with Pfizer
North Carolina will receive $45 million as part of a much larger national settlement with Pfizer.
The settlement, in which Pfizer Inc. (NYSE:PFE) will pay more than $780 million nationally, resolves allegations that Wyeth, now a subsidiary of Pfizer, “knowingly misreported sale prices and underpaid drug rebates” to Medicaid programs for the acid reflux and heartburn medication Protonix.
“Cheating Medicaid wastes tax dollars and harms health care for patients in need,” Attorney General Roy… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 29, 2016 Category: Pharmaceuticals Authors: Jason deBruyn Source Type: news
Pfizer finalizes $785M settlement to resolve allegations of underpaying Medicaid rebates
Wyeth, a subsidiary of pharmaceutical company Pfizer, finalized a $784.6 million settlement with the federal government and individual states to resolve allegations of underpaying rebates owed under the Medicaid Drug Rebate Program.
New York-based Pfizer first announced the terms of the agreement in February.
The Pennsylvania Attorney General’s office said between 2001 and 2006 Wyeth knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of Protonix Oral and Protonix… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 28, 2016 Category: Pharmaceuticals Authors: Jeff Blumenthal Source Type: news
Hawaii to recover $400K in Protonix drug settlement
Pfizer, Inc. subsidiary Wyeth will pay $784.6 million across the nation for underpaying rebates owed under the Medicaid drug rebate program.
Attorney General Doug Chin said Wednesday the State of Hawaii agreed to settle allegations against Wyeth, resolving allegations that Wyeth knowingly underpaid rebates owed under Medicaid for Protonix Oral and Protonix IV sales between 2001 and 2006. The drugs are taken for ulcers.
Under the settlement, Wyeth agreed to pay $784.6 million to the federal and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 28, 2016 Category: Biotechnology Authors: Lorin Eleni Gill Source Type: news
Pfizer finalizes $785M settlement to resolve allegations of underpaying Medicaid rebates
Wyeth, a subsidiary of pharmaceutical company Pfizer, finalized a $784.6 million settlement with the federal government and individual states to resolve allegations of underpaying rebates owed under the Medicaid Drug Rebate Program.
New York-based Pfizer first announced The terms of the agreement in February.
The Pennsylvania Attorney General’s office said between 2001 and 2006 Wyeth knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of Protonix Oral and Protonix… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 27, 2016 Category: Biotechnology Authors: Jeff Blumenthal Source Type: news
Pfizer finalizes $785M settlement to resolve allegations of underpaying Medicaid rebates
Wyeth, a subsidiary of pharmaceutical company Pfizer, finalized a $784.6 million settlement with the federal government and individual states to resolve allegations of underpaying rebates owed under the Medicaid Drug Rebate Program.
New York-based Pfizer first announced The terms of the agreement in February.
The Pennsylvania Attorney General’s office said between 2001 and 2006 Wyeth knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of Protonix Oral and Protonix… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2016 Category: Pharmaceuticals Authors: Jeff Blumenthal Source Type: news
Aurobindo Pharma gets final USFDA nod for gastro reflux drug
Aurobindo Pharma has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 31, 2016 Category: Pharmaceuticals Source Type: news
